Original Research
Published on 14 Oct 2024
Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481301
- 1,045 views
Type at least 3 characters
7,224 articles
Articles
Original Research
Published on 14 Oct 2024
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1478196
- 1,740 views
Case Report
Published on 14 Oct 2024
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1434697
- 1,245 views
Editorial
Published on 14 Oct 2024
Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor, volume III
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495465
- 427 views
Mini Review
Published on 11 Oct 2024
Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1453886
- 3,143 views
- 2 citations
Original Research
Published on 11 Oct 2024
Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446961
- 2,662 views
- 1 citation
Review
Published on 11 Oct 2024
A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1427573
- 1,849 views
Review
Published on 11 Oct 2024
Impact of mitochondrial dysfunction on the antitumor effects of immune cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1428596
- 2,076 views
Original Research
Published on 11 Oct 2024
Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF/CXCR4 axis to immune escape
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1431535
- 1,781 views
- 1 citation
Original Research
Published on 11 Oct 2024
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1386838
- 2,004 views
Review
Published on 11 Oct 2024
Genomic instability as a driver and suppressor of anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1462496
- 2,464 views
- 2 citations
Review
Published on 11 Oct 2024
Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1470468
- 2,426 views
- 1 citation
Case Report
Published on 10 Oct 2024
Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1405856
- 1,051 views
- 2 citations
Original Research
Published on 10 Oct 2024
Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1458488
- 1,236 views
Review
Published on 10 Oct 2024
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1472430
- 3,325 views
Review
Published on 10 Oct 2024
Bispecific antibody targets and therapies in multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1424925
- 3,850 views